Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v7-FR
Language English French
Date Updated 2018-08-17 2018-08-16
Drug Identification Number 02240351 02240351
Brand name INTEGRILIN INTEGRILIN
Common or Proper name Eptifibatide Injection Eptifibatide Injection
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients EPTIFIBATIDE EPTIFIBATIDE
Strength(s) 0.75MG 0.75MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 100ml 100ml
ATC code B01AC B01AC
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2018-07-30 2018-07-30
Actual start date 2018-07-27 2018-07-27
Estimated end date 2018-08-24 2018-08-24
Actual end date 2018-08-16 2018-08-16
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Limited quantity available Limited quantity available
Health Canada comments